Shopping Cart 0
Cart Subtotal
USD 0

TaiGen Biotechnology Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

TaiGen Biotechnology Co Ltd (TaiGen Biotechnology), a subsidiary of TaiGen Biopharmaceuticals Holdings Ltd, is a research-based pharmaceutical company that develops novel therapeutics for infectious diseases, cancer and diabetes-related complications. The company's pipeline products include nemonoxacin, burixafor, and TG-2349. It offers nemonoxacin, a non-fluorinated quinolone antibacterial for community acquired pneumonia, diabetic foot infection, and other indications. TaiGen Biotechnology has products under development for the treatment of various conditions such as solid tumors, hematological cancers and others. The company works in partnership with other research institutes, hospitals and pharmaceutical companies. It conducts research on anti-influenza drug and anti-gram negative bacteria drug. TaiGen Biotechnology is headquartered in Taipei, Taiwan.

TaiGen Biotechnology Co Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

TaiGen Biopharma Enters into Joint Venture with Yichang Hec Changjiang Pharma 10

TaiGen Biotech Enters MoU with HEC Pharma 11

Licensing Agreements 12

TaiGen Biotechnology Enters into Licensing Agreement with Productos Cientificos 12

TaiGen Biotech Enters Into Licensing Agreement With R-Pharm For Nemonoxacin 13

TaiGen Biotech Enters Into Licensing Agreement With Zhejiang Medicine For Nemonoxacin 14

Acquisition 16

Yichang Hec Changjiang Pharma Acquires 9% Stake in Dongguan HEC TaiGen Biopharma 16

TaiGen Biotechnology Co Ltd-Key Competitors 17

TaiGen Biotechnology Co Ltd-Key Employees 18

TaiGen Biotechnology Co Ltd-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Product Approvals 20

May 30, 2017: TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn Intravenous Formulation to the China Food and Drug Administration 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TaiGen Biotechnology Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

TaiGen Biotechnology Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

TaiGen Biopharma Enters into Joint Venture with Yichang Hec Changjiang Pharma 10

TaiGen Biotech Enters MoU with HEC Pharma 11

TaiGen Biotechnology Enters into Licensing Agreement with Productos Cientificos 12

TaiGen Biotech Enters Into Licensing Agreement With R-Pharm For Nemonoxacin 13

TaiGen Biotech Enters Into Licensing Agreement With Zhejiang Medicine For Nemonoxacin 14

Yichang Hec Changjiang Pharma Acquires 9% Stake in Dongguan HEC TaiGen Biopharma 16

TaiGen Biotechnology Co Ltd, Key Competitors 17

TaiGen Biotechnology Co Ltd, Key Employees 18

TaiGen Biotechnology Co Ltd, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com